Chemical Structure : RBN3143
CAS No.: 2360853-16-1
Catalog No.: PC-20898Not For Human Use, Lab Use Only.
RBN3143 (RBN-3143) is a potent, selective, NAD+-competitive catalytic inhibitor of PARP14 with IC50 of 4 nM, >300-fold selectivity over other ADP-ribosyltransferase (ART) family members.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $218 | In stock | |
10 mg | $358 | In stock | |
25 mg | $548 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
RBN3143 (RBN-3143) is a potent, selective, NAD+-competitive catalytic inhibitor of PARP14 with IC50 of 4 nM, >300-fold selectivity over other ADP-ribosyltransferase (ART) family members.
RBN-3143 broadly suppressed disease phenotypes such as airway mucus, serum-IgE levels, and the accumulation of immune cells and inflammatory cytokines in the BALF in a mouse model of severe, steroid-resistant asthma.
RBN-3143 also suppressed the accumulation of alarmins TSLP, IL-33, and IL-25.
RBN-3143 is the first small molecule inhibitor of PARP14 entering clinical trials.
M.Wt | 449.54 | |
Formula | C22H28FN3O4S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
7-((1-acetylpiperidin-4-yl)methoxy)-5-fluoro-2-(((tetrahydro-2H-pyran-4-yl)thio)methyl)quinazolin-4(3H)-one |
1. Niepel M, et, al. European Respiratory Journal 2022 60: 4642.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright